Please assess the completion status of the following clinical trial:

Trial Title: Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy adult male and non-pregnant female adults aged 18-40 years and healthy children aged 1-17 years~All subjects must satisfy the following criteria at study entry:~* Male or female adult residents aged 18-40 years or children aged 1- 17 years who the investigator believes will comply with the requirements of the protocol (i.e. available for follow-up visits and specimen collection)~* For females of reproductive age, they must not be pregnant (as determined by verbal screening)~* Written informed consent obtained from subjects or their guardians, and written assent for children aged 12-17 years.~* Healthy subjects as determined by: medical history, physical examination, clinical judgement of the investigator.~Exclusion Criteria:~* Ongoing serious chronic disease~* Immunocompromising condition or therapy~* Diarrhea (3 or more loose stools within a 24-hour period) 6 weeks prior to enrollment~* one or two episodes of diarrhea lasting for more than 2 weeks in the past 6 months~* one or two episodes of abdominal pain lasting for more than 2 weeks in the past 6 months~* intake of any anti-diarrhoeal medicine in the past week~* abdominal pain or cramps, loss of appetite, nausea, general ill-feeling or vomiting in the past 24 hours~* acute disease one week prior to enrollment, with or without fever. Temperature \> or = 38 degrees C (oral) or axillary temperature \> or = 37.5 degrees C warrants deferral of the vaccination pending recovery of the subject~* receipt of antibiotics in past 14 days~* receipt of live or killed enteric vaccine in last month~* receipt of killed oral cholear vaccine

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Cholera Vaccine
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).